Walleye Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Buy |
94,298
+57,332
| +155% | +$271K | ﹤0.01% | 1119 |
|
|
2025
Q1 | $170K | Buy |
+36,966
| New | +$170K | ﹤0.01% | 1455 |
|
|
2024
Q2 | – | Sell |
-19,018
| Closed | -$78.2K | – | 2992 |
|
|
2024
Q1 | $78.2K | Sell |
19,018
-86,736
| -82% | -$356K | ﹤0.01% | 2061 |
|
|
2023
Q4 | $446K | Sell |
105,754
-152,193
| -59% | -$642K | ﹤0.01% | 1199 |
|
|
2023
Q3 | $1.11M | Sell |
257,947
-43,284
| -14% | -$187K | ﹤0.01% | 848 |
|
|
2023
Q2 | $1.99M | Sell |
301,231
-14,138
| -4% | -$93.2K | 0.01% | 520 |
|
|
2023
Q1 | $2.14M | Buy |
315,369
+168,329
| +114% | +$1.14M | 0.03% | 499 |
|
|
2022
Q4 | $1.09M | Buy |
+147,040
| New | +$1.09M | 0.02% | 691 |
|
|
2022
Q3 | – | Sell |
-194,164
| Closed | -$2.12M | – | 2778 |
|
|
2022
Q2 | $2.12M | Buy |
194,164
+130,114
| +203% | +$1.42M | 0.06% | 340 |
|
|
2022
Q1 | $724K | Sell |
64,050
-44,441
| -41% | -$502K | 0.02% | 777 |
|
|
2021
Q4 | $1.7M | Buy |
+108,491
| New | +$1.7M | 0.05% | 362 |
|